New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read More
CMS
What 8 recent studies found about Medicare Advantage
(By Rylee Wilson for Becker’s Hospital Review) Recent studies have uncovered differences between networks, beneficiary characteristics and medications prescribed in
Read MoreImportant New Changes to Improve Access to Behavioral Health in Medicare
(Source – cms.gov/blog) As we emerge from the COVID-19 public health emergency, it is abundantly clear that our nation must
Read MoreCMS pitches expanded coverage of PET scans for Alzheimer’s disease
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More3 ways to reduce Medicare Advantage overpayments
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage overpayments may be higher than the the Medicare Payment and Advisory
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year
(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read MoreACA risk adjustment payments are on the rise: CMS
(By Rylee Wilson for Becker’s Hospital Review) Total risk adjustment payments in individual and small group insurance plans increased in
Read MoreHHS Announces Actions to Protect Consumers and Lower Health Care Costs
(Source – www.cms.gov/newsroom) The U.S. Department of Health and Human Services (HHS), announced actions to protect consumers from junk health
Read MoreLeqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More